Article

The Columbian on 2015-03-06 00:39

AbbVie to buy leukemia drugmaker Pharmacyclics for $21B

Related news

AbbVie to buy leukemia drugmaker Pharmacyclics for $21B neworleanscitybusiness.com
Sunnyvale , Illinois
AbbVie to buy leukemia drug maker Pharmacyclics for $21 billion LA Times
Sunnyvale , North Chicago
AbbVie to acquire Pharmacyclics for $21B The Salt Lake Tribune
Washington , Ireland
Three reasons why AbbVie bought Sunnyvale's Pharmacyclics for $21B bizjournals.com
AbbVie buys drugmaker Pharmacyclics in $21B deal USA today
Ireland
CSunnyvale's Pharmacyclics sells for $21 billion to AbbVie contracostatimes.com
Pacific Ocean , Foster City , San Francisco Bay Area , Cardiff Bay , Silicon Valley
CBiz Break: Pharmacyclics cofounder on $21B buyout -- 'This is a company that kept fighting'contracostatimes.com
Los Gatos , China , Mountain View , Wall Street , Foster City
Drugmaker AbbVie to spend over $10 billion on ImmunoGen to juice its cancer-fighting treatment portfolio pressherald.com
North Chicago , Massachusetts , Waltham
Report: J&J close to deal to buy partner Pharmacyclics Merced Sun-Star
Switzerland , New Jersey , New Brunswick , California , Sunnyvale
AbbVie closes $21 billion deal for Pharmacyclics Chicago Tribune
United States , Wall Street , California
AbbVie wins 3-company battle to buy cancer drugmaker for $21B Chicago Tribune
California
AbbVie boosts cancer drug pipeline with $21-billion Pharmacyclics deal The Globe and Mail
Canada , United States
US stocks edge higher; Pharmacyclics jumps on AbbVie bid TimesDaily.com
AbbVie to Buy Pharmacyclics in $21 Billion Deal wsj.com
Chicago
CTeva offers to buy drugmaker Mylan for $40.1B contracostatimes.com
Netherlands
Drugmaker AbbVie donates $55M to 3 education nonprofits kentucky.com